Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Epitalon: Evidence Summary
Evidence summary for Epitalon across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Epitalon overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Telomere elongation | Tier D | 1 | Khavinson studies show telomerase activation in cell cultures; human evidence minimal |
| Anti-aging / longevity | Tier D | 2 | Russian longitudinal studies suggest lifespan extension; limited Western replication |